Development of pneumococcal meningitis during ceftriaxone therapy.
Moriarty
R A
RA
Department of Pediatrics, National Naval Medical Center, Bethesda, MD 20889-5000.
D002443:Ceftriaxone / Q000008:administration & dosage / Q000627:therapeutic use*; D002555:Cerebrospinal Fluid / Q000382:microbiology; D004352:Drug Resistance, Microbial; D005260:Female; D006801:Humans; D007223:Infant; D007273:Injections, Intramuscular; D008586:Meningitis, Pneumococcal / Q000134:cerebrospinal fluid / Q000188:drug therapy* / Q000382:microbiology; D008826:Microbial Sensitivity Tests
D002443:Ceftriaxone